2021-2023年，实验室发表学术论文共398篇，其中SCI收录172篇，中文核心期刊231篇。

[1]Su, X., X. Zhang#, W. Liu, X. Yang, N. An, F. Yang, J. Sun, Y. Xing*, and H. Shang*. 2021. Advances in the application of nanotechnology in reducing cardiotoxicity induced by cancer chemotherapy', Semin Cancer Biol.（SCI 收录，IF 15.707）

[2]Jiang, K., Y. Xu, D. Wang, F. Chen, Z. Tu, J. Qian, S. Xu, Y. Xu, J. Hwa, J. Li, H. Shang, and Y. Xiang*. 2022. 'Cardioprotective mechanism of SGLT2 inhibitor against myocardial infarction is through reduction of autosis', Protein Cell, 13: 336-59.（SCI收录，IF 14.87）

[3]Yang, F., C. Liu#, X. Liu, X. Pan, X. Li, L. Tian, J. Sun, S. Yang, R. Zhao, N. An, X. Yang, Y. Gao*, and Y. Xing*. 2021. 'Effect of Epidemic Intermittent Fasting on Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials', Front Nutr, 8: 669325.（SCI 收录，IF 6.576）

[4]Xiang M, Lu Y, Xin L, Gao J, Shang C, Jiang Z, Lin H, Fang X, Qu Y, Wang Y, Shen Z, Zhao M*, Cui X*. Role of Oxidative Stress in Reperfusion following Myocardial Ischemia and Its Treatments. Oxid Med Cell Longev 2021, 2021: 6614009.（SCI 收录，IF 6.543）

[5]Lv, S., Y. Wang, W. Zhang, and H. Shang*. 2021. 'Trimethylamine oxide: a potential target for heart failure therapy', Heart. （SCI收录，IF 5.994）

[6]He, Q. Y., X. Y. Yu, Z. Xiao, X. Sun, W. F. Zhu, X. Q. Yi, Q. Chen, J. H. Zhang, S. X. Chen, X. Zhou, H. Y. Nie, H. C. Shang*, and X. F. Chen*. 2021. 'Comparison of the Efficacy of Danhong Injections at Different Time-points During the Perioperative Period of Acute Myocardial Infarction: A Systematic Review and Meta-analysis of Randomized Controlled Trials', Front Pharmacol, 12: 643446. （SCI 收录，IF 5.81）

[7]Zhang Xiaoyu, Zhao Chen, Zhang Houjun#, Liu Wenjing#, Zhang Jingjing, Chen Zhao, You Liangzhen, Wu Yuzhuo, Zhou Kehua, Zhang Lijing, Liu Yan*, Chen Jianxin*, Shang Hongcai*. Dyspnea Measurement in Acute Heart Failure: A Systematic Review and Evidence Map of Randomized Controlled Trials [J]. Frontiers in Medicine,2021,8.（SCI 收录，IF 5.091）

[8]Zhou, Y., T. Yin, M. Shi, M. Chen, X. Wu, K. Wang, I. Cheang, Y. Li, H. Shang*, H. Zhang*, and X. Li*. 2021. 'Nobiletin Attenuates Pathological Cardiac Remodeling after Myocardial Infarction via Activating PPARgamma and PGC1alpha', PPAR Res, 2021: 9947656.（SCI 收录，IF 4.964）

[9]Wei, X. H., X. Guo, C. S. Pan, H. Li, Y. C. Cui, L. Yan, J. Y. Fan, J. N. Deng, B. H. Hu, X. Chang, S. Y. He, L. L. Yan, K. Sun, C. S. Wang, and J. Y. Han*. 2021. 'Quantitative Proteomics Reveal That Metabolic Improvement Contributes to the Cardioprotective Effect of T89 on Isoproterenol-Induced Cardiac Injury', Front Physiol, 12: 653349.（SCI 收录，IF 4.566）

[10]Wang, B., Y. Li#, X. Hao, J. Yang, X. Han, H. Li, T. Li, D. Wang, Y. Teng, L. Ma, Y. Li, M. Zhao*, and X. Wang*. 2021. 'Comparison of the Clinical Value of miRNAs and Conventional Biomarkers in AMI: A Systematic Review', Front Genet, 12: 668324.（SCI 收录，IF 4.5)

[11]Qiu Ruijin, Han Songjie, Wei Xuxu, Zhong Changming, Li Min, Hu Jiayuan, Wang Pengqian, Zhao Chen, Chen Jing*, Shang Hongcai*. Development of a Core Outcome Set for the Benefits and Adverse Events of Acute Heart Failure in Clinical Trials of Traditional Chinese Medicine and Western Medicine: A Study Protocol [J]. Frontiers in Medicine,2021,8.（SCI收录，IF 4.468）

[12]Wang, P., T. He#, R. Zheng, Y. Sun, R. Qiu, X. Zhang, Y. Xing*, and H. Shang*. 2021. 'Applying cooperative module pair analysis to uncover compatibility mechanism of Fangjis: An example of Wenxin Keli decoction', J Ethnopharmacol, 278: 114214. （SCI 收录，IF 4.36）

[13]Han, X., T. Li, Y. Li, J. Yang, S. Chen, X. Zhu, B. Wang, W. Cheng, L. Wang, Z. Lu, X. Wu, Y. Jiang, G. Pan, and M. Zhao*. 2021. 'Exercise and Circulating Microparticles in Healthy Subjects', J Cardiovasc Transl Res, 14: 841-56.（SCI收录，IF 4.132）

[14]Meng, H., W. Cheng, L. Wang, S. Chen, Y. Teng, Z. Lu, Y. Li, and M. Zhao*. 2022. 'Mesenchymal Stem Cell Exosomes in the Treatment of Myocardial Infarction: a Systematic Review of Preclinical In Vivo Studies', J Cardiovasc Transl Res, 15: 317-39.（SCI 收录，IF 4.13）

[15]Hou Shiqiang, Niu Gengming, Liu Xin, Bourbon Pierre M, Zhang Dongmei, Cui Pengfei, Zhao Kevin, Zhao Dezheng, Zeng Huiyan*. A novel transcriptional complex on the VE-cadherin promoter regulated the downregulation of VE-cadherin in the down syndrome candidate region 1 isoform 1 L- mediated angiogenesis [J]. Microvascular research,2021,138.（SCI 收录，IF 3.514）

[16]Gao Yijie, Wu Dandan, Jia Dongdong, Guo Qianqian, Wang Manman, Yang Rui, Zhang Xinyue, Chen Meng, Zhang Dongmei*. Hypoxic Stem Cell-derived Extracellular Vesicles for Cardiac Repair in Preclinical Animal Models of Myocardial Infarction: a Meta-analysis [J]. Stem cells and development,2021.（SCI 收录，IF 3.272）

[17]Chen, S., X. Wu, T. Li, Y. Li, B. Wang, W. Cheng, Y. Teng, J. Yang, H. Meng, L. Wang, Z. Lu, Y. Jiang, Y. Wang*, and M. Zhao*. 2021. 'Atheroprotective Effects and Mechanisms of Postmarketing Chinese Patent Formulas in Atherosclerosis Models: A Systematic Review', Evid Based Complement Alternat Med, 2021: 4010607.（SCI 收录，IF 2.69）

[18]Liu, K., M. Lv, X. Ji, L. Lou, B. Nie, J. Zhao, A. Wu*, and M. Zhao. 2021a. 'Advances of Traditional Chinese Medicine Regulating Connexin43 in the Prevention and Treatment of Myocardial Infarction', Evid Based Complement Alternat Med, 2021: 8583285.（SCI 收录，IF 2.629）

[19]Liu, K., M. Lv, X. Ji, L. Lou, B. Nie, J. Zhao, A. Wu*, and M. Zhao.. 2021b. 'Wenxin Granules Regulate Endoplasmic Reticulum Stress Unfolded Protein Response and Improve Ventricular Remodeling on Rats with Myocardial Infarction', Evid Based Complement Alternat Med, 2021: 7375549.（SCI 收录，IF 2.629）

[20]Lou, L., C. Li, J. Wang, A. Wu, T. Zhang, Z. Ma, L. Chai, D. Zhang, Y. Zhao, B. Nie, Q. Jin, H. Chen, and W. J. Liu. 2021. 'Yiqi Huoxue preserves heart function by upregulating the Sigma-1 receptor in rats with myocardial infarction', Exp Ther Med, 22: 1308.（SCI 收录，IF 2.447）

[21]Pan, X., L. Tian, F. Yang, J. Sun, X. Li, N. An, Y. Xing, X. Su, X. Liu, C. Liu, Y. Gao*, and Y. Xing*. 2021. 'Tai Chi as a Therapy of Traditional Chinese Medicine on Reducing Blood Pressure: A Systematic Review of Randomized Controlled Trials', Evid Based Complement Alternat Med, 2021: 4094325.（SCI 收录，IF 2.629）

[22]Wu, X., T. Zhang, P. Lyu, M. Chen, G. Ni, H. Cheng, G. Xu, X. Li, L. Wang, and H. Shang. 2021. 'Traditional Chinese Medication Qiliqiangxin Attenuates Diabetic Cardiomyopathy via Activating PPARgamma', Front Cardiovasc Med, 8: 698056.（SCI 收录，IF 2.16）

[23]Yang, X., G. Li#, M. Guan#, A. Bapat#, Q. Dai, C. Zhong, T. Yang, C. Luo, N. An, W. Liu, F. Yang, H. Pan, P. Wang, Y. Gao, Y. Gong, S. Das*, H. Shang*, and Y. Xing*. 2021. 'Potential Gene Association Studies of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis', Front Cardiovasc Med, 8: 651269.（SCI 收录，IF 2.16）

[24]Qin, G., Y. Dong#, Z. Liu#, Z. Gong, C. Gao, M. Zheng, M. Tian, Y. He, L. Zhong, and P. Wang*. 2021. 'Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitro', Chin Med, 16: 128.（SCI 收录，IF 5.455）

[25]Zheng, M., Z. Liu, L. Mana, G. Qin, S. Huang, Z. Gong, M. Tian, Y. He, and P. Wang*. 2021. 'Shenzhiling oral liquid protects the myelin sheath against Alzheimer's disease through the PI3K/Akt-mTOR pathway', J Ethnopharmacol, 278: 114264.（SCI收录，IF 4.36）

[26]Zhou, D., K. Cen, W. Liu, F. Liu, R. Liu, Y. Sun, Y. Zhao, J. Chang*, and L. Zhu*. 2021. 'Xuesaitong exerts long-term neuroprotection for stroke recovery by inhibiting the ROCKII pathway, in vitro and in vivo', J Ethnopharmacol, 272: 113943.（SCI 收录，IF 4.36）

[27]Qin, G., Y. Wang#, Z. Liu#, L. Mana, S. Huang, and P. Wang*. 2021. 'Shenzhiling oral solution promotes myelin repair through PI3K/Akt-mTOR pathway in STZinduced SAD mice', 3 Biotech, 11: 361.（SCI 收录，IF 2.406）

[28]Zheng M, Wang P*. Role of insulin receptor substance-1 modulating PI3K/Akt insulin signaling pathway in Alzheimer's disease. 3 Biotech 2021, 11(4): 179. （SCI收录，IF 2.406）

[29] Zhou, D., L. Xie, X. Shi, F. Liu, S. Wu, S. Zhang, R. Liu, J. Chang, and L. Zhu*.'A meta-analysis of the clinical efficacy of Tanreqing injection combined with antibiotics vs antibiotics alone for treating pulmonary infection secondary to intracerebral hemorrhage', Medicine (Baltimore), 2021, 100: e24905. （ SCI 收 录， IF 1.889）

[30]YongXin Ru,XueBin Zhang,ShuXu Dong,Yongqiang Zhang,Ying Li,Jing Liu,YingDai Gao,HongCai Shang*,Eyden Brian. Histopathological and ultrastructural study of carotid atherosclerotic plaques: a study of four cases [J]. Ultrastructural pathology, 2021, 45(4-5). （SCI 收录，IF 1.094）

[31]J Chen，X Wei，Q Zhang，H Xia，G Xia，Y Wu，S Lin*，H Shang*. Progress of ubiquitin-proteasome system in the pathophysiology of heart failure and the intervention of traditional Chinese medicine. TMR Modern Herbal Medicine.

[32]Gao, Z.#, X. Xu#, Y. Li, K. Sun, M. Yang, Q. Zhang, S. Wang, Y. Lin, L. Lou, A. Wu, W. Liu*, and B. Nie*. 2021. 'Mechanistic Insight into PPARgamma and Tregs in Atherosclerotic Immune Inflammation', Front Pharmacol, 12: 750078.（SCI 收录，IF 5.81）

[33]Zhang, H., J. Liu#, P. Zhang#, D. Li#, G. Feng, M. Huandike, S. Sun, L. Chai*, and J. Zhou*. 2021. 'Herbal Formula Longteng Decoction Promotes the Regression of Synovial Inflammation in Collagen-Induced Arthritis Mice by Regulating Type 2 Innate Lymphocytes', Front Pharmacol, 12: 778845. （SCI 收 录，IF.5.811）

[34]Li, J., Q. Sun#, C. Zheng, C. Bai, C. Liu, X. Zhao, P. Deng, L. Chai*, and Y. Jia*. 2021. 'Lipoxin A4-Mediated p38 MAPK Signaling Pathway Protects Mice Against Collagen-Induced Arthritis', Biochem Genet, 59: 346-65. （SCI 收 录，IF 1.89）

[35]Sun, Y.*, Y. Liu*, B. Liu, K. Zhou, Z. Yue, W. Zhang, W. Fu, J. Yang, N. Li, L. He, Z. Zang, T. Su, J. Fang, Y. Ding, Z. Qin, H. Song, H. Hu, H. Zhao, Q. Mo, J. Zhou, J. Wu, X. Liu, W. Wang, R. Pang, H. Chen, X. Wang, and Z. Liu. 2021. 'Efficacy of Acupuncture for Chronic Prostatitis/Chronic Pelvic Pain Syndrome : A Randomized Trial', Ann Intern Med, 174: 1357-66.（SCI 收录，IF 25.391）

[36]Chen, Z., Y. Jiang, X. Zhang, R. Zheng, R. Qiu, Y. Sun, C. Zhao, and H. Shang*. 2022. 'ResNet18DNN: prediction approach of drug-induced liver injury by deep neural network with ResNet18', Brief Bioinform, 23.（SCI 收录，IF 11.622）

[37]Wei, X*., X. Wu, Z. Cheng, Q. Wu, C. Cao, X. Xu*, and H. Shang. 2022. 'Botanical drugs: a new strategy for structure-based target prediction', Brief Bioinform, 23.（SCI 收录，IF 11.622）

[38]Zhang, X., L. Zhang, W. Xiong, X. Wang, X. Zhou, C. Zhao, G. Tian, H. Shang, T. Wu*, J. Miao, and Z. Bian*. 2021. 'Assessment of the reporting quality of randomised controlled trials of massage', Chin Med, 16: 64.（SCI 收录，IF 5.81）

[39] Sun, X., L. Li#, Y. Liu, W. Wang, M. Yao, J. Tan, Y. Ren, K. Deng, Y. Ma, Y. Wang, J. Chen, W. Huang, Q. Xia, Y. Li, and H. Shang*. 2021. 'Assessing Clinical Effects of Traditional Chinese Medicine Interventions: Moving Beyond Randomized Controlled Trials', Front Pharmacol, 12: 713071.（SCI 收录，IF 5.455）

[40]Ge, L., H. Zhu, Q. Wang, M. Li, J. Cai, Y. Chen, Y. Chen, B. Ding, B. Fang, Y. Fei, J. Feng, X. Guo, R. Jiang, Y. Jiang, G. Li, X. Li, X. Li, Q. Liang, J. Liu, J. Liu, Q. Liu, S. Liu, Y. Lu, Q. Miao, W. Qi, H. Shang, L. Shi, X. Tan, X. Tang, X. Wang, X. Wang, W. Xia, K. Yang, L. Yang, Y. Ye, Q. Zhou, H. Zhang, J. Zhang, Z. Zhang, Z. Zhang, X. Zou, J. Li, and D. Wu. 2021. 'Integrating Chinese and western medicine for

COVID-19: A living evidence-based guideline (version 1)', J Evid Based Med, 14: 313-32.（SCI 收录，IF 5.267）

[41]Tian, G., C. Zhao, X. Zhang, W. Mu, Y. Jiang, X. Wei, M. Zhao, Z. Shi, Y. Jin, J. Si, J. Wang, J. Hu, M. Guan, R. Qiu, C. Zhong, M. Li, Y. Sun, Z. Chen, L. You, J. Li, and H. Shang*. 2021. 'Evidence-based traditional Chinese medicine research: Two decades of development, its impact, and breakthrough', J Evid Based Med, 14: 65-74. （SCI 收录，IF 5.267）

[42]Hu Jiayuan, Qiu Ruijin#, Li Chengyu, Li Min, Dai Qianqian, Chen Shiqi, Zhao Chen, Shang Hongcai. Problems with the outcome measures in randomized controlled trials of traditional Chinese medicine in treating chronic heart failure caused by coronary heart disease: a systematic review [J]. BMC Complementary Medicine and Therapies, 2021, 21(1).（SCI 收录，IF 3.659）

[43]Chen, J., J. Y. Li, G. H. Tian, R. J. Qiu, X. Q. Zhao, X. S. Di, Q. M. Yuan, S. W. Long, Y. Ran, Y. S. Jia*, and H. C. Shang*. 2021. 'A national snapshot of the impact of clinical depression on post-surgical pain and adverse outcomes after anterior cervical discectomy and fusion for cervical myelopathy and radiculopathy: 10-year results from the US Nationwide Inpatient Sample', PLoS One, 16: e0258517.（SCI收录，IF 3.24）

[44]Qiu, R. J., M. Li, J. Y. Hu, J. Chen*, and H. C. Shang*. 2021. 'Methods for development of a core outcome set for clinical trials integrating traditional Chinese medicine and Western medicine', J Integr Med, 19: 389-94. （ SCI 收 录 ， IF 3.034）

[45] Sun, Y., Y. Liu#, H. Chen, Y. Yan*, and Z. Liu*. 2021. 'Electroacupuncture for stress-predominant mixed urinary incontinence: a protocol for a three-armed randomised controlled trial', BMJ Open, 11: e038452. （ SCI 收 录 ， IF 2.692）

[46] He, F.#, W. Su#, R. Wu, H. Li, L. Lou, A. Wu, L. Xie, Y. Du*, and S. Wu*. 2021. 'The effect of cold exposure on serum cholesterol is dependent upon ApoE', J Therm Biol, 99: 102972.（SCI 收录，IF 2.9）

[47]Zhao, M. Z., C. Zhao, S. S. Tu, X. X. Wei, and H. C. Shang*. 2021. 'Evaluating the methodology of studies conducted during the global COVID-19 pandemic: A systematic review of randomized controlled trials', J Integr Med, 19: 317-26.（SCI 收录，IF2.681）

[48]Zeng, Z., M. Li, Y. Zeng, J. Zhang, Y. Zhao, Y. Lin, R. Qiu*, D. S. Zhang*, and H. C. Shang*. 2021. 'Potential Acupoint Prescriptions and Outcome Reporting for Acupuncture in Atopic Eczema: A Scoping Review', Evid Based Complement Alternat Med, 2021: 9994824.（SCI 收录，IF 2.629）

[49]Li, B., Y. Lin, B. Nie, G. Zhao, X. Zhang, M. Zhu, J. Hu, P. Huang, S.Feng, R. Qiu, G. Tian, S. Zhang, and H. Shang*. 2021. 'Systematic review and pathway enrichment analysis of Chinese medicine in preventing recurrence and improving prognosis of cholelithiasis after gallbladder-preserving lithotripsy', Ann Palliat Med, 10: 12985-3001.（SCI 收录，IF 2.465）

[50]Li, C. Y., Y. L. Chen, J. Y. Hu, M. Li, X. Y. Zhang, Y. Sun, R. Zheng, S. Q. Chen, S. J. Han, T. M. He, and H. C. Shang*. 2021. 'Status Quo and Analysis of the Cardiovascular Clinical Practice Guidelines/Expert Consensuses of Chinese and Integrative Medicine: A Systematic Review', Chin J Integr Med, 27: 54-61.（SCI 收录，IF 1.978）

[51]Zhang, X., C. Zhao#, H. Zhang#, W. Liu, J. Zhang, Z. Chen, L. You, Y. Wu, K. Zhou, L. Zhang, Y. Liu*, J. Chen*, and H. Shang*. 2021. 'Dyspnea Measurement in Acute Heart Failure: A Systematic Review and Evidence Map of Randomized Controlled Trials', Front Med (Lausanne), 8: 728772. （SCI 收录，IF 0.649）

[52]Zuo, R., L. F. Ye#, Y. Huang, Z. Q. Song#, L. Wang#, H. Zhi, M. Y. Zhang, J. Y. Li, L. Zhu, W. J. Xiao, H. C. Shang*, Y. Zhang,* R. R. He*, and Y. Chen*. 2021. 'Hepatic small extracellular vesicles promote microvascular endothelial hyperpermeability during NAFLD via novel-miRNA-7', J Nanobiotechnology, 19: 396.（SCI 收录，IF 10.435）

[53]Xia, H., Y. Liu#, G. Xia, Y. Liu*, S. Lin*. and L. Guo*. 2021. 'Novel Isoquinoline Alkaloid Litcubanine A - A Potential Anti-Inflammatory Candidate', Front Immunol, 12: 685556.（SCI 收录，IF 7.56）

[54]He, S., F. Lyu, L. Lou, L. Liu, S. Li, J. Jakowitsch, and Y. Ma*. 2021. 'Anti-tumor activities of Panax quinquefolius saponins and potential biomarkers in prostate cancer', J Ginseng Res, 45: 273-86.（SCI 收录，IF 6.046）

[55]Wang, C., M. Huandike#,Y. Yang#,, H. Zhang#,, G. Feng, X. Meng, P. Zhang, J. Liu, J. Li*, and L. Chai*. 2021. 'Glycosides of Caulis Lonicerae inhibits the inflammatory proliferation of IL-1beta-mediated fibroblast-like synovial cells cocultured with lymphocytes', Phytother Res. （SCI 收 录 ， IF 5.882）

[56]Li, Y. S., J. Zhang, G. H. Tian*, H. C. Shang, and H. B. Tang*. 2021. 'Kirenol, darutoside and hesperidin contribute to the anti-inflammatory and analgesic activities of Siegesbeckia pubescens makino by inhibiting COX-2 expression and inflammatory cell infiltration', J Ethnopharmacol, 268: 113547.（SCI 收录，IF 4.36

[57]Li, C., P. Wang#, M. Li, R. Zheng, S. Chen, S. Liu, Z. Feng, Y. Yao, and H. Shang*. 2021. 'The current evidence for the treatment of sepsis with Xuebijing injection: Bioactive constituents, findings of clinical studies and potential mechanisms', J Ethnopharmacol, 265: 113301.（SCI 收录，IF 4.36）

[58]Xia, G. Y., D. J. Fang#, L. Y. Wang, H. Xia, Y. N. Wang, H. C. Shang*, and S. Lin*. 2022. '13,13a-seco-protoberberines from the tubers of Corydalis yanhusuo and their anti-inflammatory activity', Phytochemistry, 194: 113023. （SCI收录，IF 4.072）

[59]Xia, H., G. Y. Xia, L. Y. Wang, M. Wang, Y. N. Wang, P. C. Lin, and S. Lin*. 2021. 'Bioactive sesquineolignans from the twigs of Litsea cubeba', Chin J Nat Med, 19: 796-800.（SCI 收录，IF 3.0)

[60]Xia, H., J. F. Zhang, L. Y. Wang, G. Y. Xia, Y. N. Wang, Y. Z. Wu, P. C. Lin, L. Xiong, and S. Lin*.. 2022. 'Bioactive neolignans and lignans from the roots of Paeonia lactiflora', Chin J Nat Med, 20: 210-14.（SCI 收录，IF 3.0）

[61]Ma X, Liu J, Liu C, Sun W, Duan W, Wang G, Kurihara , He R*, Li Y*,Chen Y*, Shang H*. ALOX15-launched PUFA-phospholipids peroxidation increases the susceptibility of ferroptosis in ischemia-induced myocardial damage. Signal Transduct Target Ther. 2022 Aug 15;7(1):288. doi: 10.1038/s41392-022-01090-z. (SCI收录，一区，IF 38.104)

[62]Su X#, Zhang X#, Liu W, Yang X, An N, Yang F, Sun J, Xing Y*, Shang H*. Advances in the application of nanotechnology in reducing cardiotoxicity induced by cancer chemotherapy.Semin Cancer Biol.2022 Nov;86(Pt 2):929-942.(SCI收录，一区，IF 17.012)

[63]Lv S#, Wang Y, Zhang W, Shang H*. Trimethylamine oxide: a potential target for heart failure therapy.Heart.2022 May 25;108(12):917-922. (SCI收录，IF 7.365)

[64]Jiang Y, Wang L, Lu Z, Chen S, Teng Y, Li T, Li Y, Xie Y*, Zhao M*. Brain Imaging Changes and Related Risk Factors of Cognitive Impairment in Patients With Heart Failure.Front Cardiovasc Med.2022 Jan 26;8:838680.（SCI收录，IF 6.05）

[65]Han XW#, Li T#, Wang TS, Wang BF, Li Y, Wang L, Lu ZW, Wu AM, Liu LS, Pan GZ, Zhao MJ*. Circulating Microparticles are Associated with Plaque Burden and Cause eNOS Uncoupling in Patients with Carotid Atherosclerosis.Front Pharmacol.2022 Nov 3;13:976644.（SCI收录，一区，IF 5.988）

[66]Lv S, Wang Y, Zhang W, Shang H*. The chemical components, action mechanisms,

and clinical evidences of YiQiFuMai injection in the treatment of heart failure.Front Pharmacol. 2022 Nov 24;13:1040235. doi: 10.3389/fphar.2022.1040235. （SCI收录，一区，IF 5.988）

[67]Li T#, Wang B#, Ding H#, Chen S, Cheng W, Li Y, Wu X, Wang L, Jiang Y, Lu Z,Teng Y, Su S, Han X, Zhao M*. Effect of Extracellular Vesicles From Multiple Cells on Vascular Smooth Muscle Cells in Atherosclerosis.Front Pharmacol.2022 May 10;13:857331.（SCI收录，一区，IF 5.988）

[68]Wang B#, Teng Y#, Li Y#, Lai S, Wu Y, Chen S, Li T, Han X, Zhou H, Wang Y, Lu Z, Li H, Ding Y, Ma L, Zhao M*, Wang X*. Evidence and Characteristics of Traditional Chinese Medicine for Coronary Heart Disease Patients With Anxiety or Depression: A Meta-Analysis and Systematic Review.Front Pharmacol.2022 May 5;13:854292.（SCI收录，一区，IF 5.988）

[69]An N#, Zhang G# Li Y#, Yuan C, Yang F, Zhang L*, Gao Y*, Xing Y*. Promising Antioxidative Effect of Berberine in Cardiovascular Diseases. Front Pharmacol. 2022 Mar 7;13:86535（SCI收录, 一区，IF 5.988）

[70]Li MX, Liu CR, Chen M, Shang H, Wang W, Luo XC, Li L, Qi YN, Xiong YQ, Huang SY, Wang J, Zou K, Liu XH, Tan J*, Sun X*. Effects of Motherwort Injection Versus Intramuscular Oxytocin for Preventing Postpartum Hemorrhage Among Women Who Underwent Cesarean Section. Front Pharmacol. 2022;13:859495.（SCI收录，一区，IF 5.988）

[71]Dai H#, Li H#, Wang B, Zhang J, Chen Y, Zhang X, Liu Y*, Shang H*. Efficacy of pharmacologic therapies in patients with acute heart failure: A network meta-analysis.Front Pharmacol.2022 Sep 23;13:677589.（SCI收录，一区，IF 5.988）

[72]Yang X#, Gokulnath P#, Lehmann HI, Hou Z, Yang S, You L, Zhang G, Xing Y, Lei J, Li G*, Guo S*, Shang H*. RNA modifications in aging-associated cardiovascular diseases.Front Pharmacol.2022 Sep 23;13:677589. （SCI收录，一区，IF 5.988）

[73]Wei XH, Wu YZ, Pan HE , Zhang Q, He K, Xia GY, Xia H,Lin S*,Shang H*. Proteomics revealed that mitochondrial function contributed to the protective effect of herba Siegesbeckiae against cardiac ischemia/reperfusion injury.Front Cardiovasc Med.2022 Jul 6;9:895797.（SCI收录，IF 5.846)

[74]Jia DD, Zhang XY, Guo QQ, Yang R, Yu HT, Zhao MZ, Shi L, Liu MH, Wu AM*,Zhang DM*. The Efficacy and Underlying Mechanism of Berberine against Atherosclerosis: a Meta-analysis in Preclinical Animal Studies .J Cardiovasc Pharmacol.2022 Sep 1;80(3):476-488.（SCI收录，IF 3.271）

[75]Li T#, Han X#, Chen S#, Wang B, Teng Y, Cheng W, Lu Z, Li Y, Wu X, Jiang Y, Wang L, Liu L, Zhao M*. Effects of Exercise on Extracellular Vesicles in Patients with Metabolic Dysfunction: a Systematic Review. J Cardiovasc Transl Res.2022 Jun 2.（SCI收录，IF 3.22）

[76]Meng H, Cheng W, Wang L, Chen S, Teng Y, Lu Z, Li Y*, Zhao M*. Mesenchymal Stem Cell Exosomes in the Treatment of Myocardial Infarction: a Systematic Review of Preclinical In Vivo Studies.J Cardiovasc Transl Res.2022 Apr;15(2):317-339.（SCI收录，IF 3.22）

[77]Lv M#, Yang D#, Ji XD#, Lou LX, Nie B, Zhao JL, Wu AM*, Zhao MJ. Effect of WenXin KeLi on improvement of arrhythmia after Myocardial infarction by intervening PI3K-AKT-mTOR autophagy pathway. Evid Based Complement Alternat Med.2022 Sep 29;2022:2022970.（SCI收录，IF 2.650）

[78]Chen S*, Wu X, Li T, Cheng W, Han X, Li Y, Wang B, Teng Y*, Zhao M*, Wang Y*. The Improvement of Cardiac and Endothelial Functions of Xue-Fu-Zhu-Yu Decoction for Patients with Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials. Evid Based Complement Alternat Med.2022 Feb 10;2022:2671343.（SCI收录，IF 2.650）

[79]Li Y#, Liu H#, Tian C#, An N, Song K, Wei Y, Sun Y, Xing Y*, Gao Y*. Targeting the multifaceted roles of mitochondria in intracerebral hemorrhage and therapeutic prospects. Biomed Pharmacother. 2022 Apr;148:112749.（SCI收录， IF 7.419）

[80]Li Y#, Tian C#, Wei Y#, Liu H, An N, Song K, Sun Y, Gao Y*, Gao Y*. Exploring the pharmacological mechanism of Naoxueshu oral liquid in the treatment of intracerebral hemorrhage through weighted gene co-expression network analysis, network pharmacological and experimental validation.Phytomedicine.2023 Jan;108:154530.（SCI收录，一区，IF 6.656）

[81]Song Y, Jia Q, Guan X, Kazuo S, Liu J, Duan W, Feng L, Zhang C*, Gao Y*. Herbal medicine for amyotrophic lateral sclerosis: A systematic review and meta-analysis. Front Pharmacol. 2022 Aug 31;13:946548.（SCI收录, 一区，IF 5.988）

[82]Liu H#, An N#, Wang L#, Li Y, Song K, Sun Y*, Gao Y*. Protective effect of Xingnaojing injection on ferroptosis after cerebral ischemia injury in MCAO rats and SH-SY5Y cells. J Ethnopharmacol. 2023 Jan 30;301:115836. （SCI收录，IF 5.195）

[83]Xu Y, Hu Y, Xu S, Liu F, Gao Y*. Exosomal microRNAs as Potential Biomarkers and Therapeutic Agents for Acute Ischemic Stroke: New Expectations. Front Neurol. 2022 Jan 24;12:747380.（SCI收录，IF 4.086）

[84]Song K#, Sun Y#, Liu H#, Li Y, An N, Wang L, Zhang H, Yang F, Xing Y*, Gao Y*. Network Pharmacology and Bioinformatics Methods Reveal the Mechanism of Berberine in the Treatment of Ischaemic Stroke.Evid Based Complement Alternat Med.2022 Jun 29;2022:5160329.（SCI收录，IF 2.65）

[85]Pang YZ, Tang J, Zhang QH, Liang FZ, Fang G, Zhao C, Shang HC, Wang LY*, Wang YP*.Treatment of Psoriasis Vulgaris with Medicated Thread Moxibustion of Zhuang Medicine: A Multicenter Randomized, Parallel Controlled Trial.Chin J Integr Med. 2022 Mar;28(3):208-214.（SCI收录，IF 2.626）

[86]Huang W#, Hickson LJ, Eirin A, Kirkland JL, Lerman LO*.  Cellular senescence: the good, the bad and the unknown. Nat Rev Nephrol.2022 Oct;18(10):611-627. （SCI收录，一区, IF 42.439）

[87]Zheng Q#, Wang Y, Yang H, Sun L, Zhang P, Zhang X, Guo J, Liu Y*, Liu WJ*. Cardiac and Kidney Adverse Effects of HIF Prolyl-Hydroxylase Inhibitors for Anemia in Patients With CKD Not Receiving Dialysis: A Systematic Review and Meta-analysis. Am J Kidney Dis. 2022 Nov 14:S0272-6386(22)01014-9.（SCI收录，一区,IF 11.072）

[88]Huang, W#., Zhu, X. Y., Lerman, A., Lerman, L. O*.  Extracellular Vesicles as Theranostic Tools in Kidney Disease. Clin J Am Soc Nephrol.2022 Mar 8;17(9):1418-1429. （SCI收录，一区，IF 10.614）

[89]Liu CH,Pan ZS,Wu ZL,Tang KJ,Zhong YD,Chen YJ,Xiao XX,Guo JY ,Duan SW,Cui TQ,Zhong GC,Yang ZF*,Zhong C*,Lin S *,Gao Y*. Hepatic SIRT6 modulates transcriptional activities of FXR to alleviate acetaminophen-induced hepatotoxicity. Cell Mol Gastroenterol Hepatol.2022;14(2):271-293. （SCI收录，一区, IF 8.797)

[90]Cai Y#, Feng Z#, Jia Q#, Guo J, Zhang P, Zhao Q, Wang YX, Liu YN*, Liu WJ*. Cordyceps cicadae Ameliorates Renal Hypertensive Injury and Fibrosis Through the Regulation of SIRT1-Mediated Autophagy. Front Pharmacol. 2022 Feb 10;12:801094. （SCI收录，IF 6.0)

[91]Feng G#, Li D#, Liu J#, Sun S*, Zhang P, Liu W, Zhang Y, Meng B*, Li J*, Chai L*. The Herbal Combination of Radix astragali, Radix angelicae sinensis, and Caulis lonicerae Regulates the Functions of Type 2 Innate Lymphocytes and Macrophages Contributing to the Resolution of Collagen-Induced Arthritis.Front Pharmacol.2022 Jul 19;13:964559. （SCI收录，一区，IF 5.81）

[92]Luo Q#, Wei R#, Cai Y#, Zhao Q, Liu Y*, Liu WJ*. Efficacy of Off-Label Therapy for Non-alcoholic Fatty Liver Disease in Improving Non-invasive and Invasive Biomarkers: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.Front Med (Lausanne).2022 Feb 25;9:793203. （SCI收录，一区，IF 5.1）

[93]Dong Z, Dai H, Liu W, Jiang H, Feng Z, Liu F, Zhao Q, Rui H, Liu WJ*, Liu B*. Exploring the Differences in Molecular Mechanisms and Key Biomarkers Between Membranous Nephropathy and Lupus Nephritis Using Integrated Bioinformatics Analysis. Front Genet. 2022 Jan 3;12:770902. （SCI收录, IF 4.8）

[94]Luo Q, Cai Y, Zhao Q, Jiang Y, Tian L, Liu Y*, Liu WJ*. Renal Protective Effects of Melatonin in Animal Models of Diabetes Mellitus-Related Kidney Damage: A Systematic Review and Meta-Analysis. J Diabetes Res. 2022 Jun 14;2022:3770417. （SCI收录, IF 4.1）

[95]Sun RX, Huang WJ*, Xiao Y, Wang DD, Mu GH, Nan H, Ni BR, Huang XQ, Wang HC, LiuYF, FuQ*, Zhao JX*. (2022). Shenlian (SL) Decoction, a Traditional Chinese Medicine Compound, May Ameliorate Blood Glucose via Mediating the Gut Microbiota in db/db Mice.J Diabetes Res.2022 Feb 9;2022:7802107. （SCI收录， IF 4.061）

[96]Jia Q, Guo J, Cai Y, Huang W, Zhu Z, Xia C, Guo K, Shang H, Liu Y*, & Liu W*. The Effectiveness and Safety of Abelmoschus manihot in Treating IgA Nephropathy: A Systematic Review and Meta-Analysis.Evid Based Complement Alternat Med.2022 Oct 5;2022:9730753. （SCI收录， IF 2.65）

[97]Cui HR, Zhang JY*, Cheng XH, Zheng JX, Zhang Q, Zheng R, You LZ, Han DR*, Shang H*. Immunometabolism at the service of traditional Chinese medicine.Pharmacol Res.2022 Feb;176:106081. (SCI收录，一区，IF 10.3)

[98]Hou Z, Yang X, Li Y, Chen J*, Shang H*. Electroacupuncture Enhances Neuroplasticity by Regulating the Orexin A-Mediated cAMP/PKA/CREB Signaling Pathway in Senescence-Accelerated Mouse Prone 8 (SAMP8) Mice. Oxid Med Cell Longev. 2022 Feb 4;2022:8694462. (SCI收录，一区，IF 7.37)

[99]Chen K, Li G, Cui H*, Du Y, Zheng J, Zhang Q, Li F#, Shang H#, Lei H#. Systems pharmacology and GC-MS metabolomics reveal the efficacy and mechanisms of zedoary oil on acute liver injury induced by oxidative stress. Phytomedicine.2022 Sep;104:154295. doi: 10.1016/j.phymed.2022.154295. Epub 2022 Jul 1. (SCI收录，一区， IF 6.656)

[100]Wang Q, Chen G, Chen X, Liu Y, Qin Z, Lin P*, Shang H, Ye M, He L*, Yao Z.*Development of a three-step-based novel strategy integrating DMPK with networkpharmacology and bioactivity evaluation for the discovery of Q-markers of traditional Chinese medicine prescriptions: Danlou tablet as an example.Phytomedicine. 2023 Jan;108:154511. (SCI收录， IF 6.656)

[101]Zheng R#, Sun Y#, Zhang X, Zhao C, Wang P, Chen S, Chen Z, Qiu R, Liang A*, Shang H*. Clinical features of adverse events associated with Xiyanping-Ribavirin combination: A systematic review.J Ethnopharmacol.2022 Jun 28;292:115076.（SCI收录，IF 5.2）

[102]Lai T, Guan Y, Men S, Shang H, Zhang H*. ResNet for recognition of Qi-deficiency constitution and balanced constitution based on voice. Front Psychol.2022 Dec 5;13:1043955. doi: 10.3389/fpsyg.2022.1043955.（SCI收录，IF 4.755）

[103]Liu R#, Cao X#, Liang Y, Li X, Jin Q, Li Y, Du H, Zao X*, & Ye Y*.  Downregulation of ST6GAL1 Promotes Liver Inflammation and Predicts Adverse Prognosis in Hepatocellular Carcinoma.J Inflamm Res.2022 Oct 10;15:5801-5814.（SCI收录，IF 4.631）

[104]Zhu H#, Li M#, Tian C, Lai H, Zhang Y, Shi J, Shi N, Zhao H, Yang K, Shang H,Sun X*, Liu J*, Ge L*, Huang L*. Efficacy and safety of chinese herbal medicine for treating mild or moderate COVID-19: A systematic review and meta-analysis of randomized controlled trials and observational studies. Front Pharmacol. 2022 Sep 7;13:988237. （SCI收录，IF 2.728）

[105]Qiu R, Zhong C, Wan S, Zhang Y, Wei X, Li M, Hu J, Chen S, Zhao C, Chen Z,Chen J*, Shang H*. Developing a core outcome set for assessing clinical safety outcomes of cardiovascular diseases in clinical trials of integrated traditional Chinese medicine and Western medicine: study protocol. Trials. 2022 Mar 28;23(1):239. doi: 10.1186/s13063-022-06166-3. （SCI收录，IF 2.728）

[106]Zhang Y, Guo S, Wang C, Liu X, Liu Y, Shang H, Yang P, Wang L, Zhai J, Li X*,

Jia Y*. Acupuncture for prostatectomy incontinence: study protocol for a multicenter single-blind randomized parallel controlled trial. Trials. 2022 Jan 4;23(1):9.（SCI收录，IF 2.728）

[107]Ling-YW#, Gui-Y X#, Huan X, Xiao-HW, Ya-N W，Sheng L*.(+)(-)-Yanhusamides A?C, three pairs of unprecedented benzylisoquinoline-pyrrole hetero-dimeric alkaloid enantiomers from Corydalis yanhusuo. Acta Pharm. Sin. B, 2022, (SCI收录，一区，IF 14.903)

[108]Song M,Chen ZJ ,Qiu RA ,Zhi TW,Xie WM ,Zhou YY ,Luo NH,Chen FQ,Liu F,Shen CP ,Lin S* ,Zhang FX*,GaoY*,Liu CH*. Inhibition of NLRP3-mediated crosstalk between hepatocytes and liver macrophages by geniposidic acid alleviates cholestatic liver inflammatory injury. Redox Biol.2022 Jul 14;55:102404. (SCI收录，一区，IF 10.787)

[109] Wang L*, Wang X, Lv X, Jin Q, Shang H, Wang CC, Wang L*. The extracellular

Ero1α/PDI electron transport system regulates platelet function by increasingglutathione reduction potential. Redox Biol. 2022 Apr; 50:102244.（SCI收录，IF 10.787）

[110]Xia GY, Wang LY, Xia H, Wu YZ, Wang YN, Hu HY*, Lin S*. Circularly polarized luminescence of talarolactones (+)/(?)-A and (+)/(?)-C: The application of CPL-calculation in stereochemical assignment. Chin. Chem. Lett., 2022, 33: 4253–4256. (SCI收录, 一区, IF 8.455)

[111]Wu YZ, Zhang Q, Wei XH, Jiang CX, Li XK, Shang HC*,Lin S*. Multiple anti-inflammatory mechanisms of Zedoary Turmeric Oil Injection against lipopolysaccharides-induced acute lung injury in rats elucidated by network pharmacology combined with transcriptomics.Phytomedicine.2022 Nov;106:154418.( SCI收录，一区, IF 6.656)

[112]Zhang N#, Wu YZ#, Zhong WC, Xia GY ,Xia H, Wang LY, Wei XH, Li Y, Shang H, He HW *,Lin S*. Multiple anti-non-alcoholic steatohepatitis (NASH) efficacies of isopropylidenyl anemosapogenin via farnesoid X receptor activation and TFEB-mediated autophagy.Phytomedicine.2022 Jul 20;102:154148.( SCI收录，一区，IF 6.656)

[113]Li Q#, Zhang T#, Wang Y#, Yang S, Luo J, Fang F, Liao J, Wen W*, Cui H*, Shang H*.Qing-Wen-Jie-Re Mixture Ameliorates Poly (I:C)-Induced Viral Pneumonia Through Regulating the Inflammatory Response and Serum Metabolism. Front Pharmacol. 2022 Jun 15;13:891851. doi: 10.3389/fphar.2022.891851. PMID: 35784698（SCI收录，一区, IF 5.988）

[114]Cao X#, Liang Y#, Liu R#, Zao X, Zhang J, Chen G, Liu R, Chen H, He Y, Zhang J*, Ye Y* . Uncovering the Pharmacological Mechanisms of Gexia-Zhuyu Formula (GXZY) in Treating Liver Cirrhosis by an Integrative Pharmacology Strategy.Front Pharmacol.2022 Mar 7;13:793888.（SCI收录，一区, IF 5.988）

[115]Chen Z#, Zhao M#, You L#, Zheng R, Jiang Y, Zhang X, Qiu R, Sun Y, Pan H, He T,Wei X, Chen Z, Zhao C*, Shang H*. Developing an artificial intelligence method for screening hepatotoxic compounds in traditional Chinese medicine and Western medicine combination. Chin Med. 2022 May 17; 17(1):58. doi: （SCI收录，IF 4.546）

[116]Cao X#, Chen H#, Li Z#, Li X, Yang X, Jin Q, Liang Y, Zhang J, Zhou M, Zhang N, Chen G*, Du H*, Zao X*, & Ye Y*.  Network pharmacology and in vitro experiments-based strategy to investigate the mechanisms of KangXianYiAi formula for hepatitis B virus-related hepatocellular carcinoma.Front Pharmacol.2022 Sep 5;13:985084.（SCI收录，IF 5.988）

[117]Wang LY,Xia H, Wu YZ, Wang YN,Lin PC*,Lin S*. Secoyanhusamine A, an oxidatively ring-opened isoquinoline inner salt from Corydalis yanhusuo.Front Chem.2022 Feb 1;9:831173.（SCI收录，IF 5.545)

[118]Wang M#, Li J#, Yin Y#, Liu L, Wang Y, Qu Y, Hong Y, Ji S, Zhang T, Wang N, Liu J, Cao X, Zao X*, & Zhang S*.  Network pharmacology and in vivo experiment-based strategy to investigate mechanisms of JingFangFuZiLiZhong formula for ulcerative colitis.Ann Med.2022 Dec;54(1):3219-3233. （SCI收录，IF 5.348）

[119]Zhang Q#, Wu YZ#, Ge MX, Xia GY, Xia H, Wang LY, Wei XH, He HW*,Lin S*. Paeoniflorin-free subfraction of Paeonia lactiflora Pall. shows the potential of anti-hepatic fibrosis: an integrated analysis of network pharmacology and experimental validation.J Ethnopharmacol.2022 Dec 5;299:115678. （SCI收录，IF 5.195）

[120]Wu YZ#, Xia GY#, Xia H, Wang LY, Wang YN,L L, Shang H*,Lin S*. Seco and Nor-seco isodhilarane-type meroterpenoids from Penicillium purpurogenum and the configuration revisions of related compounds.J Nat Prod.2022 Jan 28;85(1):248-255. （SCI收录，IF 4.803）

[121]Xia GY#,Fang DJ#,Wang LY, Xia H, Wang YN, Shang H*,Lin S*. 13,13a-seco-protoberberines from the tubers of Corydalis yanhusuo and their anti-inflammatory activity. Phytochemistry.2022 Feb;194:113023. （SCI收录，IF 4.004）

[122]Chen M#, Zhu H#, Zhu Q, Wu X, Zhou Y, Gao R, Shi M, Zhang T, Yin T, Zhang H*,Shang H*, Li X*. Citri Reticulatae Pericarpium alleviates postmyocardial infarction heart failure by upregulating PPARγ expression. Clin Exp Pharmacol Physiol. 2022 Jun;49(6):661-673. （SCI收录，IF 2.963）

[123]Lin S, Chen H, Nie B, Jiang C, Yang H, Wang Q*, Yuan Z*. Sleep Breath.Raw Pinelliae Rhizoma: examination of sedative and hypnotic effects in mice and chemical analysis.Sleep Breath.2022 Sep 27.（SCI收录，IF 2.655）

[124]Wang J#, Cao X#, Deng S#, Wang B, Feng J, Meng F, Xu H, Wang S, Zao X*, Li H*, Ye Y*. Effect of liver cirrhosis on erectile function in rats: A study combining bioinformatics analysis and experimental research.Andrologia.2022 Apr;54(3):e14352. （SCI收录，IF 2.532）

[125]Zhang Y#, Xia GY#, Wu YZ, Wei XH, Xia H, Wang LY, Lin PC, Wang YN, Chen LX*,Lin S*. Two new nor-seco isodhilarane-type meroterpenoids from the endophytic fungus Penicillium purpurogenum. Chem Biodivers.2022 Jul;19(7):e202200403. （SCI收录，IF 2.275）

[126]Sun KH, Yang MF, Xu XR, Li Y, Gao Z, Zhang QY, Li H, Wang SQ, Lou LX, Wu AM*, Jin QS, Wu SX*, Nie B*.Comparative Pharmacokinetics of Seven Major Compounds in Normal and Atherosclerosis Mice after Oral Administration of Simiao Yong'an Decoction.Evid Based Complement Alternat Med.2022 Apr 28;2022:4604601. （SCI收录，IF 1.984）

[127]Wang LY#,Xia GY#,Wang M,Wu YZ,Wang YN,Chai LM*,Lin S*. Penicipurate A, a new polyketide derivative from the endophytic fungus Penicillium purpurogenum. J Asian Nat Prod Res.2022 Jul 19;1-7.（SCI收录，IF 1.610）

[128]Chen J#, Wei XH#, Zhang Q, Wu YZ, Xia GY, Xia H, Wang LY, Shang HC*, Lin S* The traditional Chinese medicines treat chronic heart failure and their main bioactive constituents and mechanisms。Acta Pharmaceutica Sinica B，2023 May 13(5):1919-1955. (一区，IF 14.903)

[129]Wei XH#, Liu WJ#, Jiang W, Lan TH, Pan H, Ma MY, You LZ, Shang HC*. XinLi formula, a traditional Chinese decoction, alleviates chronic heart failure via regulating the interaction of AGTR1 and AQP1. Phytomedicine. 2023 Feb 23;113:154722. doi: 10.1016/j.phymed.2023.154722. (一区，IF 7.9)

[130]Dong-Yang Zhao#, Kai-Jing Guo#, Qian Zhang, Yan Wu, Chen Ma, Wenyi He, Xiang-Ju Jin, Xin-Yu Zhang, Yanan Wang*, Sheng Lin*, Hongcai Shang* Mechanism of XiJiaQi in the treatment of chronic heart failure: Integrated analysis by pharmacoinformatics, molecular dynamics simulation, and SPR validation .Computers in Biology and Medicine 2023.Sep(一区IF 7.7)

[131]Han SJ#, Xu QQ#, Pan H, Liu WJ, Dai QQ, Lin HY, Cui HR, You LZ, Wu YZ, Wei XH*, Shang HC*. Network pharmacology and molecular docking prediction, combined with experimental validation to explore the potential mechanism of Qishen Yiqi pills against HF-related cognitive dysfunction. J Ethnopharmacol. 2023 Oct 5;314:116570. doi: 10.1016/j.jep.2023.116570. （一区，IF 5.4）

[132]Teng Y, Li Y, Wang L, Wang B, Su S, Chen J, Lu Z, Zhu H*, Zhao M*. Effectiveness and pharmacological mechanisms of Chinese herbal medicine for coronary heart disease complicated with heart failure. Journal of ethnopharmacology 2023, 322: 117605. （一区，IF 5.4）

[133]Wang L, Lu Z, Teng Y, Pan W, Li Y, Su S, Chang J*, Zhao M*. Cognitive impairment is associated with BDNF-TrkB signaling mediating synaptic damage and reduction of amino acid neurotransmitters in heart failure. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2024, 38(1): e23351.（SCI收录， IF 4.8）

[134]Su S, Ji X, Li T, Teng Y, Wang B, Han X, Zhao M*. The changes of cardiac energy metabolism with sodium-glucose transporter 2 inhibitor therapy. Front Cardiovasc Med 2023, 10: 1291450.（SCI收录， IF 3.6）

[135]Yudi Zhuo,Jingling Chang,Yi Chen,Chunli Wen,Fei Chen,Wenhui Li,Mengxia Gao,Weibo Luo,Shurun Wan,Lianying Song*,Lingqun Zhu*. Value of contrast-enhanced MR angiography for the follow-up of treated brain arteriovenous malformations: systematic review and meta-analysis. Eur Radiol. 2023 ;33(10):7139-7148.（IF 5.9）

[136]Yuanyuan Li#,Chenxi Tao#,Na An,Haoqi Liu,Zhenhong Liu,Hongrui Zhang,Yikun Sun,Yanwei Xing*,Yonghong Gao*. Revisiting the role of the complement system in intracerebral hemorrhage and therapeutic prospects. Int Immunopharmacol. 2023 Aug 7（SCI收录，二区，IF 5.6）

[137]Wenhui Li, Xingxing Li,Yannan Li,Yi Chen,Lingqun Zhu*,Rongjuan Guo*.Diagnostic value of MicroRNAs for depression: A systematic review and meta-analysis. J Psychiatr Res. 2023;157:132-140. （SCI收录,二区， IF 4.8）

[138]Wenhui Li, Xingxing Li,Yannan Li,Yi Chen,Lingqun Zhu,Rongjuan Guo*. Association between mitochondrial DNA levels and depression: a systematic review and meta-analysis. BMC Psychiatry. 2023;23(1):8664.4.（SCI收录, IF 4.4）

[139]Mengxia Gao, Lingqun Zhu, Jingling Chang, Tianyu Cao, Lianying Song, Chunli Wen, Yi Chen, Yudi Zhuo,Fei *.Safety and Efficacy of Edaravone in Patients with Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-analysis. Clin Drug Investig. 2023;43(1):1-11.（SCI收录，IF 3.2）

[140]Qiyan Zheng # , Yahui Wang # , Huisheng Yang, Luying Sun, Pingna Zhang, Xueqin Zhang, Jing Guo, Yu Ning Liu* , Wei Jing Liu*.Cardiac and Kidney Adverse Effects of HIF Prolyl-Hydroxylase Inhibitors for Anemia in Patients With CKD Not Receiving Dialysis: A Systematic Review and Meta-analysis. Am J Kidney Dis.2023 Apr（SCI收录，一区, IF 13.2）

[141]Weijun Huang,Siting Hong,Xiangyang Zhu,Mina H Alsaeedi,Hui Tang,James D Krier,Deep Gandhi,Kyra L Jordan,Ishran M Saadiq,Yamei Jiang,Alfonso Eirin,Lilach O Lerman.Obesity Blunts the Effect of Mesenchymal Stem Cell-Derived Extracellular Vesicles. Kidney Int Rep.2023 Jul（SCI收录，二区,IF 6.0）

[142]Sinan Ai# , Yake Li# , Huijuan Zheng, Zhen Wang,Weijing Liu, JiaYin Tao , Yaotan Li and Yaoxian Wang*.Global research trends and hot spots on autophagy and kidney diseases: a bibliometric analysis from 2000 to 2022 Frontiers in Pharmacology.2023.Nov  （SCI收录，二区，IF 5.6）

[143]Meiling Zhang#, Jinjun Cheng# , Juan Luo, Changxiang Li,Tingting Hou , Yan Zhao, Yaoxian Wang *, Huihua Qu* and Hui Kong *.Protective effects of Scutellariae Radix Carbonisata-derived carbon dots on blood-heat and hemorrhage rats.Frontiers in Pharmacology.2023.Aug.10. （SCI收录，二区, IF 5.6)

[144]Li D, Liu W, Sun S, Zhang Y, Zhang P, Feng G, Wei J, Chai L*. Chinese herbal formula, modified Xianfang Huoming Yin, alleviates the inflammatory proliferation of rat synoviocytes induced by IL-1β through regulating the migration and differentiation of T lymphocytes. Journal of Ethnopharmacology. 2023 Jun 10; （SCI收录，一区，IF 5.4)

[145]Chen H, Guo J, Cai Y, Zhang C, Wei F, Sun H, Cheng C, Liu W*, He Z*. Elucidation of the anti-β-cell dedifferentiation mechanism of a modified Da Chaihu Decoction by an integrative approach of network pharmacology and experimental verification. Journal of Ethnopharmacology. 2023 Nov 23（SCI收录，一区，IF 5.4)

[146]Wang Y, Liu T, Cai Y, Liu W*, Guo J*. SIRT6's function in controlling the metabolism of lipids and glucose in diabetic nephropathy Front Endocrinol (Lausanne).2023 Oct （SCI收录，二区，IF 5.2）

[147]Mengchao L#, Jia-lin L #, Yue-fen W, Yuan M,Gui-min Z, Zhen C, Cun S, Meng-di W,Xiang-gang Z , Yang-zi C, Yu-lin W,Wen-jing Z* , Wen-quan N* and Yao-xian W*. Association between serum complements and kidney function in patients with diabetic kidney disease Trials.Front Med (Lausanne).2023 Feb 25;9:793203. （SCI收录， IF 5.2）

[148]Feng G, Zhang P, Huang J, Yu Y, Yang F, Zhao X, Wang W, Li D, Sun S, Niu X, Chai L*, Li J*. Sequential Release of Panax Notoginseng Saponins and Osteopractic Total Flavone from Poly (L-Lactic Acid) Scaffold for Treating Glucocorticoid-Associated Osteonecrosis of Femoral Head. Journal of Functional Biomaterials 2023 Jan 4;（SCI收录, 二区，IF 4.8）

[149]Yachun Li, Hongmei Lu, Jing Guo, Meiling Zhang, Huijuan Zheng, Yuning Liu

& Liu WJ*. Gut microbiota-derived trimethylamine N-oxide is associated with the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease: a systematic review and dose-response meta-analysisRes. Annals of Medicine 55:1, 2215542, DOI:10.1080/07853890.2023.2215542 （SCI收录, IF 4.4）

[150]Yuheng Qiu, Jingyi Tang, Qihan Zhao, Yuhua Jiang, Yu Ning Liu*, and Wei Jing L*.From Diabetic Nephropathy to End-Stage Renal Disease: The Effect of Chemokines on the Immune System. J Diabetes Res.2023 May（SCI收录， IF 4.3）

[151]Yi Zhen Han , Hui Juan Zheng , Bo Xuan Du , Yi Zhang , Xing Yu Zhu,Jing Li , Yao Xian Wang*,and Liu W*. Role of Gut microbiota, Immune imbalance, and Allostatic load in the Occurrence and Development of Diabetic Kidney DiseaseJournal of diabetes research..2023 Dec 5 （SCI收录， IF 4.3）

[152]Hongmei Lu, Dengpiao Xie, Bo Qu, Mingquan Li, Yuhua He* ,Weijing L*.Emodin prevents renal ischemia-reperfusion injury via suppression of p53-mediated cell apoptosis based on network pharmacology. Heliyon. 9 (2023) e15682（SCI收录， IF 4.0）

[153]Sinan Ai, Yake Li, JiaYin Tao, Huijuan Zheng, Lei Tian,Yaoxian Wang*, Zhen Wang * and Wei Jing L*,Bibliometric visualization analysis of gut-kidney axis from 2003 to 2022. Frontiers in Physiology. 2023Jun DOI 10.3389/fphys.2023.1176894（SCI收录， IF 4.0）

[154]Borui Yu, Mengqi Zhou, Zhaocheng Dong, Huijuan Zheng, Yuxue Zhao, Jingwei Zhou,Chao Zhang, Fudong Wei, Guoyong Yu, Wei Jing L, Hongfang Liu and Yaoxian Wang*.Integrating network pharmacology and experimental validation to decipher the mechanism of the Chinese herbal prescription modified Shen-Yan-Fang-Shuai formula in treating diabetic nephropathy. PHARMACEUTICAL BIOLOGY, 2023, VOL. 61, NO. 1, 1222–1233（SCI收录， IF 3.8）

[155]Liu S, Yao C, Xie J, Liu H, Wang H, Lin Z, Qin B, Wang D, Lu W, Ma X, Liu Y, Liu L, Zhang C, Xu L, Zheng R, Zhou F, Liu Z, Zhang G, Zhou L, Liu J, Fei A, Zhang G, Zhu Y, Qian K, Wang R, Liang Y, Duan M, Wu D, Sun R, Wang Y, Zhang X, Cao Q, Yang M, Jin M, Song Y, Huang L, Zhou F, Chen D, Liang Q, Qian C, Tang Z, Zhang Z, Feng Q, Peng Z, Sun R, Song Z, Sun Y, Chai Y, Zhou L, Cheng C, Li L, Yan X, Zhang J, Huang Y, Guo F, Li C, Yang Y, Shang H*, Qiu H; EXIT-SEP Investigators. Effect of an Herbal-Based Injection on 28-Day Mortality in Patients With Sepsis: The EXIT-SEP Randomized Clinical Trial. JAMA Intern Med. 2023 Jul 1;183(7):647-655.. (SCI收录，一区，IF 39)

[156]Liyuan Tao, Jiaojiao Liao, Xiaoyu Zhang , Rui Zheng , Shang H*Association of medicinal plant consumption with all-cause mortality and cognitive impairment in older adult: A large prospective cohort study Phytomedicine 119 (2023) 154995  (SCI收录，一区， IF 7.9)

[157]Liu L, Wang Y, Zhang P, Qiao H, Sun T, Zhang H, Xu X*, Shang H*. Collaborative Transfer Network for Multi-Classification of Breast Cancer Histopathological Images. IEEE J Biomed Health Inform. 2023 Jun 9;PP. doi: 10.1109/JBHI.2023.3283042. Epub ahead of print. PMID: 37294651. (SCI收录，一区， IF 7.7)

[158]Liu L, Chang J, Liu Z, Zhang P, Xu X*, Shang H*. Hybrid Contextual Semantic Network for Accurate Segmentation and Detection of Small-Size Stroke Lesions From MRI. IEEE J Biomed Health Inform. 2023 Aug;27(8):4062-4073. doi: 10.1109/JBHI.2023.3273771. Epub 2023 Aug 7. （SCI收录，一区，IF 7.7）

[159]Zheng R, Chen Z, Guan Z, Zhao C, Cui H, Shang H*. Variable importance for projection (VIP) scores for analyzing the contribution of risk factors in severe adverse events to Xiyanping injection. Chin Med. 2023 Feb 13;18(1):15. doi: 10.1186/s13020-023-00718-8. PMID: 36782216; PMCID: PMC9923652.（SCI收录，IF 4.9）

[160]You LZ, Dai QQ, Zhong XY, Yu DD, Cui HR, Kong YF, Zhao MZ, Zhang XY, Xu QQ, Guan ZY, Wei XX, Zhang XC, Han SJ, Liu WJ, Chen Z, Zhang XY, Zhao C, Jin YH, Shang H*. Clinical evidence of three traditional Chinese medicine drugs and three herbal formulas for COVID-19: A systematic review and meta-analysis of the Chinese population. J Integr Med. 2023 Sep;21(5):441-454. doi: 10.1016/j.joim.2023.08.001. Epub 2023 Aug 5. PMID: 37596131.（SCI收录，IF 4.8）

[161]Xie YL, Han F, Jin YH, Ding YB, Guo J, Ji DX, Zhang T, Chen XM, Shang H*. Organic Integration of Traditional Chinese and Western Medicines-Future of Clinical Practice Guidelines of Integrated Traditional Chinese and Western Medicines. Chin J Integr Med. 2023 Aug 2. doi: 10.1007/s11655-023-3739-9. Epub ahead of print. PMID: 37528326.（SCI收录，IF 2.9）

[162]Yi-Tong Liu#, Gui-Yang Xia#, Ying-Yi Chen, Huan Xia, Jun-Ji Xu, Li-Jia Guo*, Sheng Lin*, Yi Liu* Purpurolide C-based microneedle promotes macrophage-mediated diabetic wound healing via inhibiting TLR4-MD2 dimerization and MYD88 phosphorylation. Acta Pharmaceutica Sinica B,2023 Dec.12 (SCI收录，一区，IF 14.903)

[163]Ling-Yan Wang#, Gui-Yang Xia#, Huan Xia, Xiao-Hong Wei, Ya-Nan Wang, Sheng Lin*. (+)/(-)-Yanhusamides A-C, three pairs of unprecedented benzylisoquinoline-pyrrole hetero-dimeric alkaloid enantiomers from Corydalis yanhusuo. Acta Pharmaceutica Sinica B,2023 Feb (SCI收录，一区，IF 14.903)

[164]Guiyang Xia , Biaobing Xiao , Lingyan Wang , Huan Xia , Yuzhuo Wu , Yanan Wang ,Hongcai Shang , Sheng Lin?, (+)/(?)-Yanhusuosines A and B, two dimeric benzylisoquinoline-protoberberine alkaloid atropo-enantiomers featuring polycyclic skeletons from Corydalis yanhusuo. Chinese Chemical Letters.2023 Jur（SCI收录，IF 9.1）

[165]Li S, Du H, Gan Dn, Li X, Zao X*, Ye Ya*. Integrated analysis of single-cell and bulk RNA-sequencing reveals tumor heterogeneity and a signature based on NK cell marker genes for predicting prognosis in hepatocellular carcinoma. Frontiers in Pharmacology. 2023, 14. (SCI收录, 二区, IF 5.6)

[166]Cao X, Zhang N, Chen H, Wang W, Liang Y, Zhang J, Liu R, Li S, Yao Y, Jin Q, Guo Z, Chen Y, Gong Y, Li X, Zao X*, Ye Y*. Exploring the mechanism of JiGuCao capsule formula on treating hepatitis B virus infection via network pharmacology analysis and in vivo/vitro experiment verification. Front Pharmacol 2023, 14: 1159094.( SCI收录，二区, IF 5.6)

[167]Zhang J#, Zao X#, Zhang J#, Guo Z, Jin Q, Chen G, Gan D, Du H, Ye Y*. Is it possible to intervene early cirrhosis by targeting toll-like receptors to rebalance the intestinal microbiome? Int Immunopharmacol 2023, 115: 109627.( SCI收录，二区，IF 5.6) [41] Ling-Yan Wang, Gui-Yang Xia, Huan Xia, Xiao-Hong Wei, Sheng Lin* (±)-Yanhusuomide A, a pair of ornithine-fused benzylisoquinoline enantiomers from Corydalis yanhusuo Bioorganic Chemistry.2023 Apr 15;（SCI收录，一区, IF 5.307）

[168]Li S#, Li Z#, Du H, Zao X, Gan D, Yang X, Li X*, Xing Y*, Ye Y* Identification of pseudo-immune tolerance for chronic hepatitis B patients: Development and validation of a non-invasive prediction model. Front Public Health 2023, 11: 1137738.

（SCI收录，二区，IF 5.2）

[169]Feng G, Liu W, Yu Y, Tian B, Zhang Y, Yang F, Huang J, Zhang P, Wang W, Li D, Sun S, Niu X*, Chai L*, Li J* Angiogenesis coupled with osteogenesis in a bone tissue engineering scaffold enhances bone repair in osteoporotic bone defects. Biomedical Materials.2023 May  18 (2023) 045002（SCI收录，IF 4.0）

[170]Wang, W., Cao, X., Cao, Y. N., Liu, L. L., Zhang, S. L., Qi, W. Y., Zhang, J. X., Yang, X. Z., Li, X. K., Zao, X. B*, & Ye, Y. A*. Exploring the Molecular Mechanism of Niuxi-Mugua Formula in Treating Coronavirus Disease 2019 via Network Pharmacology, Computational Biology, and Surface Plasmon Resonance Verification. Curr Comput Aided Drug Des. Published online October 18, 2023.（SCI收录，IF 1.7）

[171]Wang M, Liu L, Wang Y, Liang Y, Li G, Lu X, Liu M, Yang H, Liu Z, Lin Z, Wang Z, Zao X*, Zhang S*. A new rat model of chronic relapsing ulcerative colitis with traditional Chinese medicine syndrome of yang deficiency and dampness stagnation. Pharmacological Research - Modern Chinese Medicine 2023, 8: 100295

[172]Zao X, Cao X, Liang Y, Zhang J, Chen H, Zhang N, Liu R, Jin Q, Chen Y, Li X, Du H, Chen G, Hou L, Ye Ya*. The Chinese herbal KangXianYiAi formula inhibits hepatocellular carcinoma by reducing glutathione and inducing ferroptosis. Pharmacological Research - Modern Chinese Medicine 2023, 8: 100276